Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
emka TECHNOLOGIES is a private life science tools company that develops hardware and software for preclinical physiology, pharmacology, toxicology, and safety pharmacology research. The company provides integrated solutions for in vivo, ex vivo, and in vitro physiologic monitoring, with strong positions in cardiovascular, respiratory, and neuroscience applications. Its commercial portfolio includes telemetry systems, non-invasive ECG and respiration systems, plethysmography, perfusion and tissue bath systems, automated microscopy and dosing tools, and analysis software such as ecgAUTO. emka TECHNOLOGIES serves academic, pharmaceutical, CRO, and translational research users globally and emphasizes technologies that improve data quality while supporting more efficient and lower-burden animal studies. The company appears to operate from Paris with a North America office in Virginia and has a long-standing installed base across thousands of systems and institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on emka TECHNOLOGIES.